Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Todd Neale

November 08, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Caitlin E. Cox

October 04, 2024

News Daily News

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Michael O'Riordan

July 23, 2024

News Daily News

Childhood Risk Factors Predict Later CVD Risk

L.A. McKeown

June 28, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Conference News AHA 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Caitlin E. Cox

November 12, 2023

News Daily News

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Caitlin E. Cox

August 01, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

L.A. McKeown

March 31, 2023

News Daily News

Longer and Greater Risk Factor Exposure, More CVD

Caitlin E. Cox

March 23, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

June 2025 Dispatch for the CV Team

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Childhood Risk Factors Predict Later CVD Risk

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

Longer and Greater Risk Factor Exposure, More CVD

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content